GSS vs RHY

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

GSS

GENETICSIG FPO [GSS]

54MEDIUM

RHY

RHYTHM BIO FPO [RHY]

50MEDIUM

Score Breakdown

GSS RHY
Technical
50
34
Catalyst
65
51
Sentiment
50
50
Fundamental
59
34
Momentum
31
50
Risk Gate
50
50

Key Metrics

GSS Metric RHY
$14.5MMarket Cap$32.2M
877KAvg Volume (20d)284K
N/AShort InterestN/A
$0.43052-Week High$0.280
$0.05752-Week Low$0.052
-1.6%Daily Change-3.3%
$0.063Reference Price$0.088
-22.8%ROE-190.1%
-56.5%Profit MarginN/A

Active Signals

GSS Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (12 quarters)
Low P/S ratio (0.7x)
EPS estimates revised downward (-10pts)
Near 52-week low (2% of range)

RHY Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Broke below 20-day support — that's a level the market was defending, and it just gave way
Lagging the Small Ords index — relative strength of 0.82, underperforming its peers
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.1 quarters)
Revenue in sharp decline (-49%)

Ask Scout AI to compare GSS and RHY in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

HIQ vs ICR →HIQ vs IDX →HIQ vs LTP →HIQ vs MYX →HIQ vs NOX →
GSS Full Analysis → RHY Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).